chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Itchy on arms; Arm is aching; Rash on arm, breaking out on both of her arms; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy on arms), PAIN IN EXTREMITY (Arm is aching) and RASH (Rash on arm, breaking out on both of her arms) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Psoriasis. Concomitant products included AMLODIPINE, HYDROCHLOROTHIAZIDE, VENLAFAXINE and OMEPRAZOLE for an unknown indication.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PRURITUS (Itchy on arms), PAIN IN EXTREMITY (Arm is aching) and RASH (Rash on arm, breaking out on both of her arms). The patient was treated with METHYLPREDNISOLONE at an unspecified dose and frequency and COCONUT OIL on 14-Mar-2021 at an unspecified dose and frequency. At the time of the report, PRURITUS (Itchy on arms) had resolved and PAIN IN EXTREMITY (Arm is aching) and RASH (Rash on arm, breaking out on both of her arms) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. Treatment included unspecified prescription cream that kind of burned her arm so she stopped that. The patient said that she had a treatment done for her psoriasis prior to receiving first vaccine dose on 9Feb2021 and was given a cream to put on in the infected places. The patient is due for a steroid shot.
As PA was sticking me in arm; Was sick; This case was reported by a consumer via interactive digital media  and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness and wrong injection technique. On an unknown date, the outcome of the sickness was recovered/resolved and the outcome of the wrong injection technique was unknown.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The patient had a new shingles shot.  It was stated that the PA was sticking vaccine in arm, which led to wrong injection technique.  The patient was feel like a sick for a few days, but it was not Covid. The patient was sick for two days and he/she rarely get sick. The patient had a friend who got shingles. She felt miserable.
Patient had a small rash (5 dots close together) on the inside of right arm.  Took a shower on Monday evening and thought he looked red.  The following morning his wife saw that he was fire red from head to toe.  He went to the doctor and received Prednisone and hydroxyzine for itching.  He also picked up a prescription for hydrocortisone 2.5 % cream.  A week later he was much better but was still experiencing itching  but most of the redness had gone away.  He is going to continue to see physician.
sore throat on right side; hard to swallow; diarrhea; soreness in my injection arm; real bad chills; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat on right side), DYSPHAGIA (hard to swallow), DIARRHOEA (diarrhea), VACCINATION SITE PAIN (soreness in my injection arm) and CHILLS (real bad chills) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 26-Nov-2020. Previously administered products included for COVID-19 vaccination: Pfizer COVID-19 vaccine in February 2021 and Pfizer COVID-19 vaccine in March 2021. Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 vaccine and Pfizer COVID-19 vaccine.    On 20-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Dec-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat on right side), DYSPHAGIA (hard to swallow), DIARRHOEA (diarrhea), VACCINATION SITE PAIN (soreness in my injection arm) and CHILLS (real bad chills). The patient was treated with EUCALYPTUS GLOBULUS OIL, MENTHOL (HALLS) for Adverse event, at an unspecified dose and frequency. At the time of the report, OROPHARYNGEAL PAIN (sore throat on right side), DYSPHAGIA (hard to swallow), DIARRHOEA (diarrhea), VACCINATION SITE PAIN (soreness in my injection arm) and CHILLS (real bad chills) outcome was unknown.            Concomitant medication of the patient was not reported.   Due to the real bad chills, the patient had to put on a jacket, socks and gloves along with 5 blankets on her. The patient took Halls cough drop, which helped some.
Starting a week after receiving the vaccine, I got a big lump at the injection site and then I developed a bruise which is unusual for me. I developed soreness and weakness which I connected to the lump. When the lump disappeared the symptoms persisted and I was more concerned. I started developing tremors and weakness making it difficult to type. I contacted my PCP and they referred me to orthopedics and neurology. Due to a family death, I was unable to follow up until after that. They first thought it may be an early onset Parkinson's but ruled it out. So, when neurology did an EMG recently it was determined that I had an entrapped nerve on the right side. They classified it as an atypical carpel and cubital nerve entrapment since it starts at the wrist and goes up the arm. They said they will treat it with braces/rest. As time goes on, it is slowly getting better so they want to watch it and not do any surgery unless it does not improve. Usually these are painful conditions, but I am not having any pain at this moment.
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. Concurrent or medical conditions were not reported. On an unknown date, the patients were vaccinated with PEDVAXHIB (dose, strength, frequency and lot number were not reported), that were improperly stored. No adverse experienced reported. This is one of two reports received from the same source. Additional information has been requested.
Headache & Myalgia Narrative: dose: 1 day 2-3 Injection site pain/muscle ache dose: 2 day 2-4 injection site pain/ day 2 and 3 muscle ache
Patient stated that she initially only had a sore arm. However about 3 days after her left beye appeared to hve a ruptured, blood vessel. She contacting the International eye institute and asked that she monitor. Cleared on its own, though worried in may happen again with her dose today. Should it occur referred her to her eye doctor,
Devel fever approx 6 hrs post inject tx APAP; had sz <2mins approx 3AM on 11JUN92 t103; seen later in AM w/lt OM;
Massive muscle pain in my abductors in both legs.  Serious arm pain in left arm immediately and still present 4 days later. Swelling  of left breast,  Left breast pain, itchiness of left breast.  Headaches for 4 days and counting.
No adverse event; an expired Moderna COVID-19 bivalent vaccine was administered; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (an expired Moderna COVID-19 bivalent vaccine was administered) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7162B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 16-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 16-Dec-2022,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (an expired Moderna COVID-19 bivalent vaccine was administered). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (an expired Moderna COVID-19 bivalent vaccine was administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (an expired Moderna COVID-19 bivalent vaccine was administered).    No concomitant medications were reported.  It was reported  that an expired Moderna COVID-19 bivalent vaccine was administered to 1 or 2 patients on 16-Dec-2022.which was placed in the refrigerator on 2-NOV-2022 and best use date was 2-Dec-2022.  No treatment medications were reported.
Patient received smallpox vaccine on 20 Feb 2004 and was then diagnosed pregnant on 18 March 2004.  Her case was reported to the DoD Smallpox Vaccine in Pregnancy Registry.
Product temperature excursion issue; No adverse event; Vaccine administered after an excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after an excursion) and NO ADVERSE EVENT (No adverse event) in an 11-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR5186C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 18-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 18-Jul-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after an excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after an excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Product temperature excursion issue) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after an excursion).    No concomitant medications were reported. Reporter stated that the duration of the excursions was 2 hours and a half, maximum temperature reached was 8.76 degree Celsius and minimum temperature reached was -4.5 degree Celsius. Vials was still frozen after the excursion.  It was reported that there were no adverse reactions to the Covid vaccines given and it was determined even though there was a temperature excursion one time that the vaccines was still viable and can be used until the end of the day on 17-Aug-2022. No treatment medications were reported.
This spontaneous report as received from a nurse refers to a 15 year old female patient. The patient's pertinent medical history and concomitant medications were not reported. On 19-AUG-2015, the patient was vaccinated with the first dose of GARDASIL 9 (lot # L019286, expiration date 14-SEP-2017, dose, route of administration and anatomical location not reported). On an unknown date in August 2015 (reported as "a few hours" after vaccination, the patient experienced dizziness, nausea, headache, and left arm numbness. The patient's symptoms lasted "a couple days" before resolving. The patient's mother decided that the patient would not receive any additional doses of GARDASIL 9. The outcome of dizziness, nausea, headache, and left arm numbness was reported as recovered (on an unknown date in 2015). The patient's brother received two doses of GARDASIL 9: first dose on 19-AUG-2015 (lot # L019286, expiration date 14-SEP-2017) and the second dose on 03-NOV-2015 (lot# L014198, expiry date 05-SEP-2017). No adverse events were reported for the patient's brother. The relatedness between the adverse events and GARDASIL 9 was not provided. Additional information has been requested.
Feeling like crap after recieving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling like crap after recieving the vaccine) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Feeling like crap after recieving the vaccine). At the time of the report, MALAISE (Feeling like crap after recieving the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided by the reporter. No treatment medication was provided.   This case was linked to MOD-2021-400115 (Patient Link).
The night of the vaccination, patient had 99.5 degree fever, body aches, low energy, low nausea. The symptoms lasted 1 and 1/2 days.
Bad flu like symtoms, welps and rash on arms and legs.  Took benadryl and cold meds, did not help.  Took alieve back and muscle, it helped with the pain and fever; took allegra for the allergic reaction and it helped.  Rash is still present
Pfizer-BioNTech COVID-19 Vaccine EUA.  Tinnitus in both left and right ears. Onset was 18 hours after vaccine dose.  Continuing unresolved tinnitus at 4 days after dose administered.  Separate Headache and hangover symptoms have resolved and started 18 hours after dose and subsided 42 hours after.
Site: Pain at Injection Site-Mild, Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: close to fainting several times-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hyperventilation-Mild, Systemic: Nausea-Medium, Systemic: Shakiness-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Weakness-Medium, Additional Details: Specifically tingling in Hands. Patient was very disoriented and appeared close to fainting a couple of times post vaccination. Was closely monitored for 30 minutes. He did not think it was due to being nervous, he was slightly nervous before the vaccine, but nothing of concern.
Pain in area surrounding right knee started in afternoon of 03/24/21 and it caused me to limp.  By that evening, the pain increased so that it was excruciating and I could not walk or put any pressure on it; even using crutches was difficult.  Area around knee also was swollen.  It was very painful to extend and bend my knee; very difficult for me to walk and go up & down stairs.  I did not fall or slam my knee/leg recently nor did I take any different medications; the only thing different I had done was get the Pfizer vaccine the day before.  Pain continued through the night; I was able to sleep but woke up several times.  The next morning pain had subsided a little to where I could walk slowly with a limp.
pt recv vax & 24hr later pt arm near the site turned, was itchy, the center of the rash was swollen;pt came into office today;9MAR98 & RN noted reddened area size of quarter on rt arm;
Within four hour of administration she began to experience extreme fatigue, chills, fever 99.5, subjective fever, arm pain rated 7 and loss arm strength, burning sensation down arm, throughout right side.  Patient slept for 12 hours and began to feel better 48 hours later.  Patient states she feels fully recovered.
Although patient reported no pain immediately afterwards, her left arm begain getting progressively more painful a few hours after administration and continues to persist despite treatment from her primary care provider. She reports burning pain in her whole arm that keeps her up at night.
Tongue was swollen and red; Roof of her mouth was swollen and painful; tongue was swollen and red; roof of her mouth was swollen and painful; A spontaneous report was received from a 76-years-old  patient concerning herself who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events tongue was swollen and red, roof of her mouth was swollen and painful, tongue feels better and can still feel something on her tongue.  The patient's medical history provided was she was a cancer survivor. Concomitant medications reported were blood pressure medications unknown indication.  On 12 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) Intramuscularly for prophylaxis of COVID-19 infection.  On 15 Feb 2021, the patient experienced the events tongue was swollen and red, roof of her mouth was swollen and painful. On an unknown date, the patient experienced the events tongue feels better and can still feel something on her tongue.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  On 22 Feb 2021 the outcome of events, tongue was swollen and red, roof of her mouth was swollen and painful was resolved.
24-year-old male with no prior medical problems presents for evaluation of chest pain.  Patient complains of midsternal chest pain that started approximately an hour ago.  He states that it woke him up from sleep.  Pain is sharp without any radiation or other associated symptoms including diaphoresis presyncopal symptoms or palpitations.  He denies any significant air hunger or shortness of breath.  He otherwise had been feeling better after what he tall was post COVID vaccine symptoms.  Patient received a 2nd dose of pfizer vaccine 3 days ago.  He states that within 24 hours he had symptoms of myalgia fever and feeling unwell.  That has been resolving patient has been feeling better until the chest pain today. Patient otherwise denies any other medical problems in.  He denies any history of drug use including any recent cocaine or other drug abuse.   Elevated cardiac enzymes and chest discomfort are likely secondary to myocarditis and secondary to vaccination/ inflammatory reaction.  Although there is low likelihood of obstructive coronary artery disease as well.  I recommended cardiac catheterization for clarification.  He does not want to have the procedure done, understands the risk of undiagnosed coronary artery disease and risk of MI.  He would like to be discharged home.    I reviewed the images of echocardiogram and it seems that he has a small area of hypokinesis in infero basal segment.   Recommended to take aspirin and be seen in Cardiology office in 2 weeks.  Advised to abstain from exercise and significant physical activity till that time and return to the hospital if any symptoms.       Subjective:   I saw patient in consultation for evaluation of chest pain and elevated cardiac enzymes.   Patient is a 24-year-old healthy male who had COVID-19 vaccination with his second Pfizer shot 4/14/21. He developed fever, chills, nausea and vomiting 1 day after vaccination.  He did not have any reaction to the 1st dose.   He presented to the hospital with substernal chest discomfort which woke him up from sleep, radiated to throat and had a throbbing feeling.  This lasted for 1 to 2 hours and subsided completely in the hospital.   He smokes 5 cigarettes a day, is physically very active and exercises regularly.  He is not on any medication at home.
PATIENT WAS GIVEN THE VACCINE DUE TO A LOW TITER TO IT BUT WE REALIZED AFTER THE FACT THAT IT EXPIRED 01/22/2023 / SHOULD WE ADMINISTER AGAIN / PATIENT IS FINE NO ISSUES; PATIENT WAS GIVEN THE VACCINE DUE TO A LOW TITER TO IT BUT WE REALIZED AFTER THE FACT THAT IT EXPIRED 01/22/2023 / SHOULD WE ADMINISTER AGAIN / PATIENT IS FINE NO ISSUES; This spontaneous report has been received from healthcare professional via Pfizer and Genaes, referring to a 9-year-old White hispanic or latino female patient.  The patient's medical history was not reported. The patient's concurrent conditions included down's syndrome. Concomitant therapies were not reported. The patient had no known allergies.  On unknown dates, the patient was administered patient started therapy with pneumococcal vaccine and Haemophilus b (hib) vaccine vaccine (formulation, strength, dose, vaccination scheme, route of administration and anatomical location, indication, lot number and expiration date were not provided)  On 16-MAR-2023 09:45, the patient was vaccinated with an expire dose pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) syringe injection, administered for prophylaxis in the thigh (lot #U018632 confirmed to be valid, expiration date not reported but stablished as 11-JAN-2023; strength, and route of administration were not provided) (ex); and at an unknown hour, hib vaccine conj (tet tox) (ACTHIB), dose number 6, lot# UJ756AA, administered in the right leg (strength, formulation, expiry date, route of administration, and indication were not provided). The patient was administered those vaccines as experienced on an unspecified date a low titer (antibody test negative). As the pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) vaccines was administered after expire date the reported inquired if the vaccine should administer again. It was reported also that the patient was fine, no issues. The outcome of the event was not reported.  The causality assessment between the suspect therapies and the event was not provided.
Information has been received from a nurse practitioner concerning a female in her 60's who on 24-JUN-2008 was vaccinated with a dose of ZOSTAVAX (Oka/Merck) (lot number was not provided). On 26-JUN-2008 the patient developed cellulitis and herpetic outbreak. The patient went to hospital for an oral antibiotic, but was not admitted. The patient had swelling, redness, and blistering and it was said it was a herpetic outbreak. The patient was noted to be recovering. No product quality complaint was involved. Additional information has been requested.
Fever of 101.6 for 12 hours, dizziness, and swelling of the site. Redness and swelling persisited for 6 days.
fell down after the Pfizer vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FALL (non-serious), outcome "unknown", described as "fell down after the pfizer vaccine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
5/20/22cough with hypoxia, brought to hospital from a facility, positive for covid on 5/20/22
This case was reported by a healthcare professional, via another manufacturer, and described the occurrence of leg numbness in a female subject of unspecified age who was vaccinated with influenza vaccine (GlaxoSmithKline). In November 2012 the subject received a dose of influenza vaccine (unknown details). In 2012, less than one week after vaccination with influenza vaccine ("about one week afterwards"), the subject experienced leg numbness and lack of blood circulation in both legs. The lack of blood circulation in both legs was described as "a sensation similar to when your circulation has been cut off from sitting on your legs too long." The healthcare professional also reported that "this numbness has made walking more difficult." At the time of reporting the outcome of the events were unspecified.